Florian Klein - associated principal investigator at the CMMC - receives DZIF Prize for translational infection research

11/28/2016

Florian Klein’s main goal is to improve HIV therapy with the help of antibodies and to develop a HIV vaccine. His research on a new generation of broadly neutralising antibodies has found worldwide recognition: the German Center for Infection Research (DZIF)

now honours Professor Klein, University Hospital Cologne, with the DZIF Prize for translational research. The prize, worth 5,000 euros, was awarded at the DZIF Annual Meeting in Cologne.

Florian Klein is associated member of the Center for Molecular Medicine Cologne (CMMC) and his Laboratory is located at the CMMC-Research Building on the campus of the University of Cologne.

The press relase of the DZIF:
http://www.dzif.de/en/news_media_centre/news_press_releases/view/detail/artikel/florian_klein_receives_dzif_prize_for_translational_infection_research/

 

Contact

Prof Florian Klein
T +49 221 478 89693
florian.klein[at]uk-koeln.de
https://klein-lab.de/

DZIF Press Office
Janna Schmidt and Karola Neubert
T +49 531 6181 1170/115
presse[at]dzif.de
http://www.dzif.de